The chemical class Cldn34c1 Inhibitors represents a theoretical group of compounds with the potential to indirectly modulate the activity or expression of the tight junction protein Claudin 34C1. These compounds are not direct inhibitors; instead, they act on various signaling pathways and cellular processes that can influence the tight junctions where Cldn34c1 is a component. Tight junctions are dynamic structures that regulate paracellular transport between epithelial or endothelial cells, and the integrity and function of these junctions are critical for maintaining barrier function.
The activity of Cldn34c1 within tight junctions can be influenced by the modulation of signaling pathways such as TGF-β, Rho, and Wnt, which are involved in the regulation of tight junction assembly and disassembly. Compounds like SB431542, Y-27632, and IWP-2 target these pathways, leading to changes in the molecular composition and function of tight junctions, thereby indirectly affecting the role of Cldn34c1. Other signaling molecules such as Akt, GSK-3, and Protein kinase A are also involved in tight junction regulation, and inhibitors of these kinases, such as MK-2206, LiCl, and H-89, can lead to alterations in tight junction dynamics.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Inhibits TGF-β type I receptor ALK5, potentially altering tight junction dynamics and indirectly affecting Cldn34c1 activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibits Rho-associated kinase, which can lead to the reorganization of tight junction proteins, impacting Cldn34c1 indirectly. | ||||||
EGTA | 67-42-5 | sc-3593 sc-3593A sc-3593B sc-3593C sc-3593D | 1 g 10 g 100 g 250 g 1 kg | $21.00 $65.00 $120.00 $251.00 $815.00 | 23 | |
Chelates calcium, disrupting cell adhesion and potentially impairing tight junctions, consequently affecting Cldn34c1. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, possibly altering tight junction assembly and indirectly impacting Cldn34c1. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
Inhibits Wnt production, potentially regulating claudin expression and tight junction assembly, affecting Cldn34c1. | ||||||
MK-2206 dihydrochloride | 1032350-13-2 | sc-364537 sc-364537A | 5 mg 10 mg | $182.00 $332.00 | 67 | |
Inhibits Akt signaling, which can influence tight junction composition, possibly impacting Cldn34c1. | ||||||
Amiloride • HCl | 2016-88-8 | sc-3578 sc-3578A | 25 mg 100 mg | $22.00 $57.00 | 6 | |
Blocks sodium channels, potentially influencing epithelial cell tight junctions and Cldn34c1 function. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Enhances tight junction barrier function, which can potentially affect Cldn34c1 localization and function. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A broad-spectrum protein kinase inhibitor, potentially altering tight junction integrity and Cldn34c1 function. | ||||||